Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 30, 2025, Calithera Biosciences (CALA) has a market cap of $24,362 Dollars USD. According to our data, Calithera Biosciences is ranked No.9312 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 30, 2025 | $24,362 Dollars |
4,899.90%
|
| Dec 31, 2024 | $0.00 M |
-99.67%
|
| Dec 29, 2023 | $0.15 M |
-99.08%
|
| Dec 30, 2022 | $15.88 M |
-75.50%
|
| Dec 31, 2021 | $64.82 M |
-86.45%
|
| Dec 31, 2020 | $0.48 B |
-14.01%
|
| Dec 31, 2019 | $0.56 B |
42.39%
|
| Dec 31, 2018 | $0.39 B |
-51.98%
|
| Dec 29, 2017 | $0.81 B |
156.92%
|
| Dec 30, 2016 | $0.32 B |
-57.57%
|
| Dec 31, 2015 | $0.75 B |
-62.08%
|
| Dec 31, 2014 | $1.97 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
USA
|
 Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
USA
|
 Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
Canada
|
 Arcus Biosciences
RCUS
|
$0.86 B |
-0.000 M
|
USA
|
 Kura Oncology
KURA
|
$0.53 B |
0.000 M
|
USA
|
 Syndax Pharmaceuticals
SNDX
|
$1.18 B |
0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.71 B |
-0.000 M
|
USA
|
 Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
 MacroGenics
MGNX
|
$0.10 B |
-0.000 M
|
USA
|
 Nektar Therapeutics
NKTR
|
$0.14 B |
-0.000 M
|
USA
|
 Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
USA
|
 Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
UK
|
 G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
| Market Cap | = | CALA Stock Price | * | CALA Shares Outstanding |
| = | $0.00 | * | 4.87 M | |
| = | $24,362 Dollars |